Compare Roblox Corp (RBLX) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roblox Corp vs Twist Bioscience Corp — how do they compare? Roblox Corp trades at $49.83 (market cap $37.59B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Roblox Corp is far larger — about 6.3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| RBLX | TWST | |
|---|---|---|
Market Cap | $37.59B | $5.97B |
Sector | Media | Health |
52-Week High | $141.56 | $102.88 |
52-Week Low | $41.30 | $24.16 |
Enterprise Value | $36.18B | $5.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Roblox trades at $52.50, up 1.59% with neutral technical signals. The company shows strong revenue growth reaching $4.89B in 2025 but continues to report significant losses with a -20.69% net margin. Analyst consensus is bullish with a $59.62 price target, though multiple class action lawsuits filed in July 2026 create near-term uncertainty. Operating cash flow improved to $1.8B, supporting ongoing platform investments.
Roblox presents a growth investment case with expanding user engagement and AI innovation, but profitability challenges and legal risks require careful monitoring. The stock offers 13.6% upside to consensus target, though high P/S ratio of 7.03 and negative ROE of -295.16% highlight valuation concerns amid persistent losses.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
